Prothrombin Fragment 1+2 and Intensity of Treatment with Oral Anticoagulants

• References

• 1 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991; 65: 153-9
• 2 Aronson DL, Stevan L, Ball AP, Franza Jr BR, Finlayson JS. Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma. J Clin Invest 1977; 60: 1410-8
• 3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotie state in humans: insights gained from studies using markers of the hemostatic system activation. Blood 1987; 70: 343-50
• 4 Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F₂/F₁₊₂ fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-97
• 5 Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1989; 80: 1535-44